The briefing
Researchers at The Ohio State University Comprehensive Cancer Center report that inhibiting the protein SET may make glioblastoma cells more vulnerable to treatment. The findings could inform new therapeutic strategies against a cancer that often resists current care.
Original headline
Study points to new target for treating aggressive brain cancer